Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...
Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management. For Episode 7 of The Independent Advantage’s Season 2, Diana ...
Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologies." Susan Gromacki, OD, MS, FAAO, FSLS, discussed ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...
Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness. Alcon has received FDA approval for apraclonidine ophthalmic solution 0.125% (Brytly) redness relief ...
Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...
The US FDA Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to review new drug application ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results